Publication | Closed Access

Glucagon-like peptide 1 (GLP-1) analogue combined with insulin reduces HbA1c and weight with low risk of hypoglycemia and high treatment satisfaction

ObesityMetabolic SyndromeDiabetes ManagementHealth SciencesGlucagon-like Peptide 1MedicineInsulin ManagementPhysiologyDiabetesHigh Treatment SatisfactionEndocrinologyDiabetes MellitusInsulin DeliveryMetabolismPharmacologyInsulin SignalingInsulin Reduces Hba1c